Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a

Aliment Pharmacol Ther. 2018 Jun;47(11):1556-1557. doi: 10.1111/apt.14657.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Hepatitis B e Antigens*
  • Hepatitis B, Chronic*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha
  • Polyethylene Glycols
  • Recombinant Proteins
  • Seroconversion

Substances

  • Hepatitis B e Antigens
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a